Pharmaceutical Market India's Pharmaceutical Market Growths Quickly

Editor: Dominik Stephan

Good news for the Indian pharmaceutical industry: Analysts see a 21 percent increase of sles for November 2011. The recent rupee depreciation however could lead to factual mark-to-market losses, analysts fear.

Related Companies

(Picture: PROCESS India)
(Picture: PROCESS India)

Mumbai/India – The Indian pharmaceutical stays on a steep growth curve: According to the All India Organisation of Chemists and Druggist (AIOCD), the Indian drugmakers were able to increase their yearly month–on–month sale by 21 percent in November. With sales of Rs 491,2 million in November, the figures significantly exceeded the Rs 468,8 million of October 2011. "This is indicative of flare-up in viral and bacterial infections," said AIOCD director Ameesh Masurekar.

Once the the seasonal demand for viral and bacterial infection drugs is met, Masurekar expects revenue growths to fall to around 14 – 15 percent. With good sales figures for November however, companies' revenues during the fourth quarter of 2011 should improve – at a time when most drugmakers are expected to post mark-to-market loss due to rupee depreciation.